Report Summary

Antidepressants: promising candidates are Servier and Novartis's melatonin agonist and serotonin antagonist Valdoxan (agomelatine)

With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial potential and the most promising candidate to date is Servier and Novartis's melatonin agonist and serotonin antagonist Valdoxan (agomelatine).

This is a database product. For more information please use the 'Enquire About Report' link on this page.

Reasons to Purchase

*Quantify the current (2008) and future (2009-2018) size of the antidepressant drug class market.

*Assess the impact of recent and anticipated events (patent expiries and new product launches) on the antidepressant drug class market.

*Understand the country-specific impact of key events in the antidepressant drug class market during the forecast period 2009 to 2018.

What are Interactive Models?

Interactive Models are databases that contain historical and forecast market and product data, industry figures and forecasts in an excel format that's easy to search and manipulate.

How do Interactive Models work?

The raw data for the model sits at the back end of the excel deliverable. At the front end, the client can add or remove categories to the data set already provided, manipulate geographies & categories, thus make their own analysis and derive results. This enhances the functionality of the model and makes it interactive.

Our Interactive Models cover a variety of topics across the Pharmaceutical, Technology, Automotive, Retail and Energy industries.

Why buy an Interactive Model?

An Interactive Model allows you to...

Manipulate the data to suit your research needs.
Access raw and comprehensive data.
Gain easily accessible data which can be used in any format e.g. Power Point, Word, Excel.
Benefit from the Universal Excel deliverable format.